Fibrinogen-mimicking, multiarm nanovesicles for human thrombus-specific delivery of tissue plasminogen activator and targeted thrombolytic therapy. (2021)
Attributed to:
Future Vaccine Manufacturing Hub: Advancing the manufacture and deployment of cost effective vaccines
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1126/sciadv.abf9033
PubMed Identifier: 34078604
Publication URI: http://europepmc.org/abstract/MED/34078604
Type: Journal Article/Review
Volume: 7
Parent Publication: Science advances
Issue: 23
ISSN: 2375-2548